COMPANY

Peak Performance Peptides

Name: Peak Performance Peptides peptide roles
Creator: Global Peptide Index
License: https://globalpeptideindex.com/methodology

Peak Performance Peptides: warning letter recipient for Retatrutide, Semaglutide, as stated by public registers.

WARNING LETTER RECIPIENT

Received an FDA warning letter naming the peptide.

Retatrutide	Unapproved New Drugs/Misbranded, 2026-08-24 Regulator FDA warning letters
Semaglutide	Unapproved New Drugs/Misbranded, 2026-08-24 Regulator FDA warning letters

What a register states, not an endorsement or an accusation by this site. All companies.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.